Regencell Bioscience Holdings Limited (RGC) Stock Price & Analysis
Regencell Bioscience Holdings Limited (RGC) closed at USD 9.52 on Thursday, October 15, 2026, up 17.39% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 8.11; the Oct 15, 2026 session ranged USD 7.72–11.12 on volume of 1,901,928 shares. Market capitalization is $4.72B, with a 52-week range of USD 4.51–69 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:22 UTC.
Also available as compact Markdown for AI agents: nexqual.com/RGC.md
Key facts (RGC)
- Analysts: None.
- Total return with dividends: 1Y -47.0% vs S&P 500 +18.1%; 5Y +1840.8% vs S&P 500 +85.1%.
- Next earnings: 2026-10-28, EPS estimate USD —, revenue estimate null.
Analysts (RGC)
Consensus None.
Total return (dividends reinvested) (RGC)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -47.0% | +1840.8% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -47.1% | +80.7% |
| Volatility (annualized) | 139.1% | 187.7% |
| Max drawdown | -91.0% (Jan 2026→Jul 2026) | -92.1% (Jun 2022→Jun 2024) |
Key Statistics (as of October 16, 2026 at 05:22 UTC)
| Price | USD 9.52 |
|---|---|
| Change | ▲ 17.39% (up) |
| Previous Close | USD 8.11 |
| Open | USD 7.98 |
| Day Range | USD 7.72 – 11.12 |
| 52-Week Range | USD 4.51 – 69 |
| Volume | 1,901,928 shares |
| Market Cap | $4.72B |
| Exchange | NCM |
Technical Analysis (RGC)
Nexqual's technical model rates RGC "BUY" based on 5 bullish and 2 bearish signals across 127 daily candles, as of October 16, 2026 at 05:22 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 78.6 (overbought) |
| vs SMA50 | Above (USD 6.14) |
| MACD | 0.63 (positive) |
Analyst Ratings (RGC)
Wall Street analysts rate RGC "None", per Nexqual as of October 16, 2026 at 05:22 UTC.
| Consensus Rating | None |
|---|
Earnings (RGC)
| Next Earnings Date | 2026-10-28 |
|---|
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Financials & Fundamentals (RGC)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -128.53% |
| Debt / Equity | 0.02 |
| Current Ratio | 10.77 |
| Total Cash | $14.19M |
| Total Debt | $295,811 |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Financial Health Score (RGC)
Nexqual rates Regencell Bioscience Holdings Limited's overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:22 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Strong — $14M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$8M (TTM) |
| Efficiency | Critical — ROE -129%, ROA -71.5% |
Ownership (RGC)
| Insider Ownership | +88.42% |
|---|---|
| Institutional Ownership | +0.29% |
| Shares Outstanding | 495.88M |
| Float | 55.62M |
| Short % of Float | +1.16% |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Leadership (RGC)
Regencell Bioscience Holdings Limited is led by Yat-Gai Au (age 52), Founder, Chairman & CEO, per Nexqual as of October 16, 2026 at 05:22 UTC.
| Founder, Chairman & CEO | Yat-Gai Au (age 52) |
|---|---|
| Financial Controller, CFO & Principal Financial Officer | Michelle Chan |
| COO, Chief Strategy Officer & Director | Wai Hong Chung (age 47) |
| Senior Vice President of Project Management | Antonia Assang |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals Interna | USD 79.94 | ▲ 1.8% |
| LNTH | Lantheus Holdings, Inc. | USD 99.99 | ▼ 0.03% |
| HIMS | Hims & Hers Health, Inc. | USD 29.38 | ▼ 1.11% |
| ALKS | Alkermes plc | USD 40.1 | ▲ 0.93% |
| INDV | Indivior Pharmaceuticals, Inc. | USD 33.62 | ▼ 5.08% |
| AMRX | Amneal Pharmaceuticals, Inc. | USD 19.25 | ▼ 1.64% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:22 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt